Wuliang Wang

589 total citations
28 papers, 201 citations indexed

About

Wuliang Wang is a scholar working on Obstetrics and Gynecology, Cancer Research and Oncology. According to data from OpenAlex, Wuliang Wang has authored 28 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Obstetrics and Gynecology, 9 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Wuliang Wang's work include Endometrial and Cervical Cancer Treatments (13 papers), Cervical Cancer and HPV Research (8 papers) and Uterine Myomas and Treatments (4 papers). Wuliang Wang is often cited by papers focused on Endometrial and Cervical Cancer Treatments (13 papers), Cervical Cancer and HPV Research (8 papers) and Uterine Myomas and Treatments (4 papers). Wuliang Wang collaborates with scholars based in China, Japan and Greece. Wuliang Wang's co-authors include Yuling Liu, Hu Zhao, Jia Liu, Chenyang Wang, Chunlin Chen, Xiaoqin Lu, Ping Liu, Xiaonong Bin, Jinquan Cui and Pengfei Li and has published in prestigious journals such as Journal of Clinical Oncology, Endocrinology and Life Sciences.

In The Last Decade

Wuliang Wang

23 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wuliang Wang China 8 68 64 53 49 47 28 201
Justin Harold United States 8 48 0.7× 65 1.0× 37 0.7× 38 0.8× 73 1.6× 18 186
И. В. Берлев Russia 9 73 1.1× 57 0.9× 65 1.2× 95 1.9× 60 1.3× 74 234
S. Suchetha India 9 48 0.7× 71 1.1× 32 0.6× 82 1.7× 55 1.2× 35 235
Elena Giudice Italy 8 93 1.4× 50 0.8× 38 0.7× 74 1.5× 134 2.9× 33 240
Angelika Kaufmann United Kingdom 8 92 1.4× 51 0.8× 30 0.6× 77 1.6× 93 2.0× 14 207
Nikola Hájková Czechia 9 79 1.2× 44 0.7× 37 0.7× 61 1.2× 69 1.5× 25 194
Beata Maćkowiak-Matejczyk Poland 8 57 0.8× 66 1.0× 28 0.5× 125 2.6× 96 2.0× 14 243
Maria Lycke Sweden 8 90 1.3× 49 0.8× 92 1.7× 145 3.0× 29 0.6× 12 276
Daliah Tsoref Israel 6 66 1.0× 56 0.9× 33 0.6× 52 1.1× 59 1.3× 15 166
David Huntsman Canada 2 66 1.0× 56 0.9× 72 1.4× 136 2.8× 57 1.2× 3 216

Countries citing papers authored by Wuliang Wang

Since Specialization
Citations

This map shows the geographic impact of Wuliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wuliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wuliang Wang more than expected).

Fields of papers citing papers by Wuliang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wuliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wuliang Wang. The network helps show where Wuliang Wang may publish in the future.

Co-authorship network of co-authors of Wuliang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wuliang Wang. A scholar is included among the top collaborators of Wuliang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wuliang Wang. Wuliang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Westin, Shannon N., Kathleen N. Moore, Michael S. Guy, et al.. (2025). Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for endometrial cancer: Longitudinal changes in circulating tumor DNA.. Journal of Clinical Oncology. 43(16_suppl). 5512–5512.
3.
Liu, Pan, Hongwei Zhao, Lixin Sun, et al.. (2023). Impact of HR-HPV infection on oncological outcomes in early cervical cancer. Frontiers in Oncology. 13. 1264114–1264114. 1 indexed citations
7.
Lu, Xiaoqin, et al.. (2023). Identification of stemness subtypes and features to improve endometrial cancer treatment using machine learning. Artificial Cells Nanomedicine and Biotechnology. 51(1). 57–73. 6 indexed citations
8.
Chen, Zhilong, Zhen Xu, Qian Wang, et al.. (2023). Exosome-delivered circRNA circSYT15 contributes to cisplatin resistance in cervical cancer cells through the miR-503-5p/RSF1 axis. Cell Cycle. 22(20). 2211–2228. 11 indexed citations
9.
Chen, Chi, Weili Li, Zhenyu Liu, et al.. (2022). The pathological risk score: A new deep learning‐based signature for predicting survival in cervical cancer. Cancer Medicine. 12(2). 1051–1063. 24 indexed citations
10.
Duan, Hui, Jianxin Guo, Ying Yang, et al.. (2022). Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study. Annals of Translational Medicine. 10(2). 122–122. 7 indexed citations
14.
Li, Pengfei, Ziyu Fang, Weili Li, et al.. (2020). Impact of neoadjuvant chemotherapy on the postoperative pathology of locally advanced cervical squamous cell carcinomas: 1:1 propensity score matching analysis. European Journal of Surgical Oncology. 47(5). 1069–1074. 2 indexed citations
15.
Chen, Chunlin, Wuliang Wang, Ping Liu, et al.. (2019). <p>Survival After Abdominal Q-M Type B versus C2 Radical Hysterectomy for Early-Stage Cervical Cancer</p>. Cancer Management and Research. Volume 11. 10909–10919. 15 indexed citations
16.
Li, Yuankun, et al.. (2018). Characterizing the landscape of peritoneal exosomal microRNAs in patients with ovarian cancer by high‑throughput sequencing. Oncology Letters. 17(1). 539–547. 14 indexed citations
17.
Zhao, Hu, et al.. (2016). BCL3 exerts an oncogenic function by regulating STAT3 in human cervical cancer. OncoTargets and Therapy. Volume 9. 6619–6629. 27 indexed citations
18.
Lu, Xiaoqin, et al.. (2016). Human wings apart-like gene is specifically overexpressed in cervical cancer. Oncology Letters. 12(1). 171–176. 2 indexed citations
19.
Liu, Jia, et al.. (2015). Expression of immune checkpoint molecules in endometrial carcinoma. Experimental and Therapeutic Medicine. 10(5). 1947–1952. 33 indexed citations
20.
Xu, Min, et al.. (2013). Polymorphisms in the MT-ATP6 and MT-CYB genes in in vitro fertilization failure. Mitochondrial DNA. 26(1). 20–24. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026